15575-04-9

Basic information

• Product Name: DECAPRENOL
• Synonyms: DECAPRENOL;N-DECAPRENOL;(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecen-1-ol;Betulaprenol-10
• CAS NO: 15575-04-9
• Molecular Formula: C₅₀H₈₂O
• Molecular Weight: 699.19
• Mol File: 15575-04-9.mol

Chemical Properties

• Melting Point: 39.5-40.5 °C
• Boiling Point: 732.5±29.0 °C(Predicted)
• Appearance: /
• Density: 0.890±0.06 g/cm3(Predicted)
• PKA: 14.42±0.10(Predicted)
• CAS DataBase Reference: DECAPRENOL(CAS DataBase Reference)
• NIST Chemistry Reference: DECAPRENOL(15575-04-9)
• EPA Substance Registry System: DECAPRENOL(15575-04-9)

Safety Data

• Hazardous Substances Data: 15575-04-9(Hazardous Substances Data)

Upstream product

• 50848-64-1 2E,6E,10E-geranylgeranyl bromide 
• 37905-04-7 (2E,6E)-8-bromo-3,7-dimethylocta-2,6-dienyl acetate 
• 37905-03-6 8-hydroxygeranyl acetate 
• 37905-02-5 (2E,6E)-3,7-dimethyl-8-oxoocta-2,6-dien-1-yl acetate 
• 68778-93-8 (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-ol 
• 105-87-3 3,7-dimethyl-2E,6-octadien-1-yl acetate 
• 909247-30-9 (4E,8E,12E,16E,20E,24E,28E,32E)-2-Acetyl-5,9,13,17,21,25,29,33,37-nonamethyl-octatriaconta-4,8,12,16,20,24,28,32,36-nonaenoic acid ethyl ester 
• 65717-26-2 Solanesylacetone 
• 52610-77-2 solanesyl bromide 
• 59640-02-7 3,7,11,15,19,23,27,31,35,39-decamethyl-1,6,10,14,18,22,26,30,34,38-tetracontadecaene-3-ol 
• 116854-31-0 4-phenylsulfonyl-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2E,6E,10E,14E,18E,22E,26E,30E,34E,37-decaen-1-ol 
• 68799-83-7 (all-E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl bromide 
• 13190-97-1 solanesol 
• 68731-63-5 1-methyl-4-{[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]sulfonyl}benzene 

Downstream Products

• 303-98-0 ubidecarenone 
• 523-40-0 Vitamin K(2⁽⁵⁰⁾) 
• 65085-29-2 2-((2Z,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone 
• 83626-19-1 4-acetoxy-6-decaprenyl-2,3,5-trimethylphenol 
• 83679-56-5 Acetic acid 3-((2Z,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-4-hydroxy-2,5,6-trimethyl-phenyl ester 
• 83626-13-5 Acetic acid 4-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyloxy)-2,3,6-trimethyl-phenyl ester 
• 83679-55-4 Acetic acid 4-((2Z,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyloxy)-2,3,6-trimethyl-phenyl ester 
• 80101-76-4 Benzoic acid 4-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyloxy)-2,3-dimethoxy-6-methyl-phenyl ester 
• 80101-83-3 4-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyloxy)-2,3-dimethoxy-6-methyl-phenol 
• 947156-48-1 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-benzene-1,4-diol 
• 144296-59-3 C₅₉H₈₆⁽²⁾H₆O₄ 

Related news

Fully unsaturated DECAPRENOL (cas 15575-04-9) from bovine pituitary glands08/29/2019

Two types of bovine pituitary gland polyprenols were resolved by silica gel chromatography; i. e., the high molecular weight dolichols of 17 to 23 isoprene units with the OH-terminal isoprene residue saturated, and a fully unsaturated decaprenol. The latter compound was found to be a mixture of ...detailed

Relevant articles and documents

An improved convergent strategy for the synthesis of oligoprenols

A practical and highly regio- and stereoselective synthesis of oligoprenols starting from commercially available geraniol is described. The convergent synthetic strategy features the iterative allyl-allyl coupling of monomers easily derived from geraniol that contain one reacting terminal functional group and the repetitive reductive elimination of the p-toluenesulfonyl (Ts) groups.

Synthesis and spectroscopic characterisation of 13C-labelled ubiquinone-0 and ubiquinone-10

(1-13C)-, (2-13C)-, (3-13C)-, (3-13CH3)-, (4-13C)-, and (13CH3O)2-ubiquinone-10 and the corresponding (1-13C)-, (6-13C)-, (5-13C)-, (5-13CH3)-, (4-13C)-, and (13CH3O)2-ubiquinone-0 have been synthesised from simple labelled starting materials via a single reaction scheme.The ubiquinones have been characterised using mass spectrometry, 1H NMR and 13C NMR.The spectroscopic results indicate that, within experimental error, the syntheses have been accomplished without scrambling or dilution of label.All labelled ubiquinones have been synthesised on a decigram scale.

SYNTHESIS OF all-(E)-DECAPRENOL AND ITS 2Z ISOMER

C5-chain growth in the structure of natural solanesol, isolated from tobacco, was realized by a C3 + C2 scheme.Decaprenol was separated into isomers with respect to the newly formed double bond by column chromatography on silica gel.The isomeric compositi

β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound

A β,γ-dihydropolyprenyl alcohol derivative having the formula: STR1 wherein n is an integer of 5 to 7 and R is hydrogen, a lower alkyl group or an aliphatic or aromatic acyl group, is new and useful as a phylactic agent against human and animal infectious diseases. Other disclosed polyprenyl compounds are also useful as such agents.

Stereoselective Synthesis of Solanesol and all-trans-Decaprenol

Allylic p-tolyl sulphonates (5), (14), and (16) couple with allylic bromide (7) and geranyl bromide to produce regio- and stereo-chemically pure 1,5-diene systems.The coupling of all-trans-ω-bromogeranyl acetate (7) with geranyl p-tolyl sulphone (5) and higher isoprenologues (21), (24), and (27), followed by reductive elimination of p-tolylsulphonyl group, furnishes a stereoselective synthesis of all-trans-polyprenols (3), (23), (26), and decaprenol (1b).Solanesol (1a) was synthesised using trans-4-chloroprenyl acetate (29) instead of (7).

Antiulcer compounds

α-Tocopheryl derivatives, useful as agents for the treatment of ulcer, are described.

Hypertension treating agent containing polyprenyl alcohol

This invention relates to a hypertension treating agent comprising a polyprenyl alcohol or an ester thereof of the general formula: STR1 wherein n represents an integer of 7-10 and A represents a group of the general formula: STR2 in which a and b each represent hydrogen or they may form a bond, or STR3 in which R represents hydrogen or --COR', R' being a saturated or unsaturated aliphatic hydrocarbon group of 1-17 carbon atoms; cyclohexyl group; unsubstituted phenyl group or phenyl group substituted with a halogen atom or a lower alkoxy group; (halogen atom-substituted phenoxy)-lower alkyl group; or pyridyl group.